Gene · 2548
Papers2,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A structural and functional analysis of opal stop codon translational readthrough during Chikungunya virus replication. | J Gen Virol | 2023 | 37862073 | PubTator, text mining | PubMed |
| Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinoma. | J Transl Med | 2023 | 37848935 | PubTator, text mining | PubMed |
| Case report: Chronic pain in a pediatric patient with late-onset pompe disease. | Front Pain Res (Lausanne) | 2023 | 37841659 | PubTator, text mining | PubMed |
| Two fluorimetric determinations of acid α-glucosidase activity in dried blood spot: Pompe disease in Iranian population. | Anal Biochem | 2023 | 37821037 | PubTator, text mining | PubMed |
| The frequency of Duchenne muscular dystrophy/Becker muscular dystrophy and Pompe disease in children with isolated transaminase elevation: results from the observational VICTORIA study. | Front Pediatr | 2023 | 37818166 | PubTator, text mining | PubMed |
| Sarcomeric gene variants among Indians with hypertrophic cardiomyopathy: A scoping review. | Indian J Med Res | 2023 | 37787257 | PubTator, text mining | PubMed |
| Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease. | Pharmaceuticals (Basel) | 2023 | 37765007 | PubTator, text mining | PubMed |
| Integrated Multi-Omics Profiling of Young Breast Cancer Patients Reveals a Correlation between Galactose Metabolism Pathway and Poor Disease-Free Survival. | Cancers (Basel) | 2023 | 37760606 | PubTator, text mining | PubMed |
| Are Anti-rhGAA Antibodies a Determinant of Treatment Outcome in Adults with Late-Onset Pompe Disease? A Systematic Review. | Biomolecules | 2023 | 37759814 | PubTator, text mining | PubMed |
| A Comprehensive Update on Late-Onset Pompe Disease. | Biomolecules | 2023 | 37759679 | PubTator, text mining | PubMed |
| Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes. | Biology (Basel) | 2023 | 37759559 | PubTator, text mining | PubMed |
| Identification of a muscle-specific isoform of VMA21 as a potent actor in X-linked myopathy with excessive autophagy pathogenesis. | Hum Mol Genet | 2023 | 37756622 | PubTator, text mining | PubMed |
| Dose selection for biological enzyme replacement therapy indicated for inborn errors of metabolism. | Clin Transl Sci | 2023 | 37735717 | PubTator, text mining | PubMed |
| Frequency of actionable secondary findings in 7472 Korean genomes derived from the National Project of Bio Big Data pilot study. | Hum Genet | 2023 | 37728764 | PubTator, text mining | PubMed |
| Patient-derived iPSC models of Friedreich ataxia: a new frontier for understanding disease mechanisms and therapeutic application. | Transl Neurodegener | 2023 | 37726850 | PubTator, text mining | PubMed |
| Screening data from 19 patients with late-onset Pompe disease for a phase I clinical trial of AAV8 vector-mediated gene therapy. | JIMD Rep | 2023 | 37701327 | PubTator, text mining | PubMed |
| Polymyositis: A Case Report. | Cureus | 2023 | 37700938 | PubTator, text mining | PubMed |
| Comparative multi-omic analyses of cardiac mitochondrial stress in three mouse models of frataxin deficiency. | Dis Model Mech | 2023 | 37691621 | PubTator, text mining | PubMed |
| Combined sequence and copy number analysis improves diagnosis of limb girdle and other myopathies. | Ann Clin Transl Neurol | 2023 | 37688281 | PubTator, text mining | PubMed |
| Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement. | Int J Mol Sci | 2023 | 37686045 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2548/papers?page=13